2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Head & Neck
2
Plasma cell
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Neoplasms
47
Breast Neoplasms
32
Colorectal Neoplasms
28
Prostatic Neoplasms
27
Lung Neoplasms
16
Hematopoietic and Lymphatic System Neoplasm
12
Hematologic Neoplasms
12
Ovarian Neoplasms
11
Uterine Cervical Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Multiple Myeloma
7
Lymphoma
7
Leukemia
7
Head and Neck Neoplasms
6
Endometrial Neoplasms
6
Depression
6
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Urinary Bladder Neoplasms
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Malignant Solid Neoplasm
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Gastrointestinal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Anxiety Disorders
4
Advanced Cancer
4
Interventions
Iodine-131
21
lenvatinib
17
Magnetic Resonance Spectroscopy
17
trametinib
13
Sorafenib
13
Thyrotropin Alfa
12
pembrolizumab
11
dabrafenib
11
Thyroidectomy
10
Surgical Procedures, Operative
10
Thyroxine
9
Paclitaxel
9
vandetanib
8
selpercatinib
8
Sunitinib
7
Nivolumab
7
Fluorodeoxyglucose F18
7
cabozantinib
6
anlotinib
6
Everolimus
6
Biopsy
6
pazopanib
5
Vemurafenib
5
Triiodothyronine
5
Specimen Handling
5
Saline Solution
5
Radiotherapy
5
Radiofrequency Ablation
5
Iodine-124
5
Cyclophosphamide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Interviews as Topic
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled
NCT06322160
2024-09-19
HANSOM
Royal Marsden NHS Foundation Trust
Completed
19 enrolled